4554 — Fuji Pharma Co Income Statement

0.000.00%

Last trade - 00:00

HealthcareBalancedSmall CapSuper Stock

Annual income statement for Fuji Pharma Co, fiscal year end - September 30th, JPY millions except per share, conversion factor applied.

	2021 September 30th	2022 September 30th	2023 September 30th	2024 September 30th	2025 September 30th
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Yuho	Yuho	Yuho	Yuho	Yuho
Standards:	JAS	JAS	JAS	JAS	—
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	33,990	35,426	40,889	46,138	51,677
Cost of Revenue
Gross Profit	14,751	14,559	16,515	17,844	20,763
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	30,675	31,937	36,787	40,914	47,467
Operating Profit	3,315	3,489	4,102	5,224	4,210
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	3,371	3,723	4,399	8,276	4,000
Provision for Income Taxes
Net Income After Taxes	2,433	2,697	3,436	6,148	3,000
Minority Interest
Net Income Before Extraordinary Items
Net Income	2,433	2,697	3,436	6,148	3,000
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	2,432	2,696	3,435	6,146	3,000
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	102	131	147	226	151
Dividends per Share
Special Dividends per Share